These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29237362)

  • 1. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
    Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
    Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant malignancies in liver transplant recipients.
    Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
    Liu ZN; Wang WT; Yan LN;
    Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo tumors after liver transplantation: a single-institution experience.
    Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
    Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo malignancy after lung transplantation in Japan.
    Miyazaki T; Oto T; Okumura M; Date H; Shiraishi T; Okada Y; Chida M; Kondo T; Nagayasu T
    Gen Thorac Cardiovasc Surg; 2016 Sep; 64(9):543-8. PubMed ID: 27270709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Malignant Neoplasms in Renal Transplant Patients.
    Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
    Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
    Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
    Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
    Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
    Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of de novo malignancies in liver transplantation].
    Catalina MV; de Diego A; García-Sánchez A; Escudero M; Salcedo M; Bañares R; Clemente G
    Gastroenterol Hepatol; 2003 Feb; 26(2):57-63. PubMed ID: 12570889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation.
    Aguiar D; Martínez-Urbistondo D; D'Avola D; Iñarrairaegui M; Pardo F; Rotellar F; Sangro B; Quiroga J; Herrero JI
    Ann Transplant; 2017 Mar; 22():141-147. PubMed ID: 28302995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.